Can anticoagulants slow or prevent the progression of thromboangiitis obliterans (Buerger’s disease), and how do they influence treatment outcomes in patients with this rare vascular condition?
Gaurav ChauhanContributor
Can anticoagulants influence the progression of thromboangiitis obliterans (Buerger’s disease)?
Share
Anticoagulants are not typically used to treat Buerger’s disease as they do not slow disease progression, focusing instead on smoking cessation and avoiding cold exposure.